SCHEMBL985541

SCHEMBL985541

CS[S+](C)C.F[B-](F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10361845 1.00
SCHEMBL8376357 0.96
SCHEMBL3401100 0.82
SCHEMBL8884033 0.75
SCHEMBL334765 0.71
SCHEMBL10361273 0.69
SCHEMBL8773237 0.69
Methylsulfanylmethane SCHEMBL27757771 0.67
Lithium Ion SCHEMBL5804711 0.67
SCHEMBL7472614 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116836389-B Low-temperature-curable positive photosensitive resin, resin composition, preparation method and application thereof 明士(北京)新材料开发有限公司 2024-01-26 CN claimed
CN-116836388-B Positive photosensitive resin, resin composition, preparation method and application thereof 明士(北京)新材料开发有限公司 2023-12-15 CN claimed
CN-116836389-A Low-temperature-curable positive photosensitive resin, resin composition, preparation method and application thereof 明士(北京)新材料开发有限公司 2023-10-03 CN claimed
CN-116836388-A Positive photosensitive resin, resin composition, preparation method and application thereof 明士(北京)新材料开发有限公司 2023-10-03 CN claimed
CN-116068852-B Positive photosensitive resin composition and preparation method and application thereof 明士(北京)新材料开发有限公司 2023-07-14 CN claimed
CN-116068852-A Positive photosensitive resin composition and preparation method and application thereof 明士(北京)新材料开发有限公司 2023-05-05 CN claimed
WO-2023047338-A1 PRODRUG INCORPORATED sgRNA SYNTHESIS CRISPR THERAPEUTICS AG (CH) 2023-03-30 WO claimed
CN-115548438-A Electrolyte additive and application thereof, lithium ion battery electrolyte and lithium ion battery 比亚迪股份有限公司 2022-12-30 CN claimed
WO-2022068900-A1 POSITIVE PHOTOSENSITIVE POLYAMIDE ESTER RESIN AND COMPOSITION USING SAME 明士(北京)新材料开发有限公司 2022-04-07 WO claimed
US-6555665-B1 With a thioglycoside as a glycoside donor in the presence of a thiophilic promoter; stereoselectivity, high yield; hydrolysing product to obtain Morphine-6-beta-D-glucuronide (M6G) CENES LIMITED (GB) 2003-04-29 US claimed
EP-0401263-A1 NEW ERGOLINE DERIVATIVES, PROCESS FOR PRODUCING THEM AND THEIR USE AS DRUGS SCHERING AKTIENGESELLSCHAFT (DE) 1990-12-12 EP claimed
WO-1989008109-A1 NEW ERGOLINE DERIVATIVES, PROCESS FOR PRODUCING THEM AND THEIR USE AS DRUGS SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) 1989-09-08 WO claimed
EP-0190534-B1 PROCESS FOR THE PREPARATION OF ERGOLINE DERIVATIVES SCHERING AKTIENGESELLSCHAFT (DE) 1988-11-30 EP claimed
EP-0190534-A1 Process for the preparation of ergoline derivatives SCHERING AKTIENGESELLSCHAFT (DE) 1986-08-13 EP claimed
JP-6263792-A None JP disclosed
JP-8073488-A None JP disclosed
EP-4036098-B1 SYNTHESIS OF REVERSIBLE NUCLEOTIDE TERMINATORS BY IN-SITU THIO-ALKYL GROUP TRANSFER FOR USE IN DNA SEQUENCING BY SYNTHESIS MILTENYI BIOTEC BV & CO KG (DE) 2026-01-28 EP disclosed
EP-0190534-B1 PROCESS FOR THE PREPARATION OF ERGOLINE DERIVATIVES SCHERING AKTIENGESELLSCHAFT (DE) 1988-11-30 EP disclosed
US-4731367-A 2-substituted ergolines useful as neuroleptics and antidepressants SCHERING AKTIENGESELLSCHAFT (DE) 1988-03-15 US disclosed
EP-0190534-A1 Process for the preparation of ergoline derivatives SCHERING AKTIENGESELLSCHAFT (DE) 1986-08-13 EP disclosed